NHI vs SRPT · P/E 22, rev $54.4M vs rev $1.13B
National Health Investors Inc (NHI) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
National Health Investors Inc (NHI) is a reit - healthcare facilities company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported NHI revenue for 2024-12-31 was $54.4M. Net income was $136.6M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. NHI currently screens at market cap $3.31B and trailing P/E 22.4.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
NHI currently screens at market cap $3.31B and trailing P/E 22.4. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the NHI and SRPT stock pages for the full models.
Not investment advice.